CRISPR Technology Market Report | Cas9 Industry Analysis, size & Forecast

A quick peek into the report

Report Description

The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene the

The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process. The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.

The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into ‘product’, ‘application’, and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.

The key players who have been contributing significantly to the CRISPR technology market include Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GenScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Key Questions Answered in this Report

How did the CRISPR technology market evolve, and what is its scope in the future?

Market Overview

The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene the

Every year, around 7.9 million children are born with genetic disorders, worldwide. Also, the genetic diseases have been responsible for 20-30% of the infant’s deaths worldwide and constitute approximately 25% of the global economic burden for diseases. The increasing economic burden of genetic diseases can be reduced by focusing on gene therapeutics supported by biomarker study, lifestyle modification, and disease screening methods that enable early detection. Furthermore, the increasing environmental factors, such as chemical factors, radioactive factors, and biological factors, has elevated the mutation rate, which elevated the need for the development of best gene therapeutic procedures, personalized medicine, and diagnostic procedures with less turnaround time.

Several conglomerate companies and startups based out of the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada, among others, have been making significant investments in the field of life sciences to develop promising gene therapy procedures to promote global health. The advent of CRISPR technology has transformed the field of genome editing by reducing the turnaround time and complexity, enhancing the accuracy, efficiency, and safety, and encouraged numerous innovations. Researchers demonstrated the potential applications of CRISPR technology to provide one-time gene therapy procedure for several genetic disorders, such as haemophilia, sickle cell anemia, and beta thalassemia, and cancers. Also, the CRISPR technology proved to repair genetic errors in an individual’s DNA, treating the root cause of the disease. Many companies, such as CRISPR Therapeutics AG, are planning to initiate clinical trials in 2018 for the treatment of various genetic disorders.

The purpose of the study is to gain a holistic view of the CRISPR technology market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products associated with the global CRISPR technology market, across different regions. The global CRISPR technology market is segmented into three different parts namely by product, by application, and by region. The global market value was estimated using these three different approaches and was validated with one another. The global CRISPR technology market is expected to reach $10.55 billion by 2027.

With the increasing demand for advancements in application specific products across the various segments of the CRISPR technology, the CRISPR technology market is expected to witness rapid growth in the future. Further, the swift expansion of the gene therapy procedures in the developed markets such as the U.S., Japan, Germany, and the U.K. is the key driver for growth of the CRISPR technology market. Moreover, the plasmids sub-segment dominated the global CRISPR technology market in 2017 in terms of products. However, the proteins sub segment is anticipated to witness the highest CAGR during the forecast period. The therapeutics and drug discovery application specific CRISPR technology witnessed the highest industry demand. Besides, the CRISPR technology specific to industrial biotech are also expected to witness impressive CAGR during the forecast period.

Based on the region the global CRISPR technology market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). North America is the leading contributor to the global CRISPR technology market and contributed 39% of the global market values in 2017. However, Europe is expected to grow at a CAGR of 36.80% during the forecast period followed by Asia Pacific region.

The key players who have significant contributions to the global CRISPR technology market are Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GenScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Request a Sample

1.1   Introduction
1.2   CRISPR Technology Approach
1.3   Evolution of CRISPR Technology
1.4   CRISPR Technology: Areas of Interest
1.5   CRISPR Technology: Future Potential
1.6   Global Market
1.7   Assumptions and Limitations

2.1   Overview
2.2   Impact Analysis
2.3   Market Drivers
2.4   Market Restraints
2.5   Market Opportunities

3.1   Introduction
3.2   Key Developments and Strategies
3.3   Product Launches and Enhancements
3.4   Joint Ventures, Partnerships and Collaborations
3.5   Mergers and Acquisitions
3.6   Business Expansions, Awards, Recognitions, Certifications and Others
3.7   Industry Attractiveness
3.7.1   Bargaining Power of Suppliers
3.7.2   Bargaining Power of Buyers
3.7.3   Threat of New Entrants
3.7.4   Threat of Substitute Products
3.7.5   Intensity of Competitive Rivalry
3.8   Pipeline Analysis

4.1   Introduction
4.2   Patent Analysis
4.3   Funding Scenario
4.3.1   Funding Scenario: Public Companies
4.3.2   Funding Scenario: Private Companies
4.3.3   Funding Scenario: Investments by Government Organizations
4.4   Legal Requirements and Regulations
4.5   List of Regulatory Bodies

5.1   Overview
5.2   Designing Tools
5.3   Library
5.4   Control Kits
5.5   Plasmids
5.6   Vectors
5.7   Proteins
5.7.1   Cas9
5.7.2   Cpf1
5.7.3   Others
5.8   Grna
5.9   Others

6.1   Overview
6.2   Biological Research
6.3   Agricultural Biotech
6.4   Industrial Biotech
6.5   Therapeutics and Drug Discovery

7.1   Overview
7.2   Global Insights
7.3   North America
7.3.1   North America Market Dynamics
7.3.2   North America Market, by Country
7.3.2.1   The U.S.
7.3.2.2   Canada
7.4   Europe
7.4.1   Europe Market Dynamics
7.4.2   Europe Market, by Country
7.4.2.1   The U.K.
7.4.2.2   Germany
7.4.2.3   France
7.4.2.4   Spain
7.4.2.5   Italy
7.4.2.6   Switzerland
7.4.2.7   Rest of the Europe
7..5   Asia Pacific
7.5.1   Asia Pacific Market Dynamics
7.5.2   Asia Pacific, by Country
7.5.2.1   Japan
7.5.2.2   China
7.5.2.3   South Korea
7.5.2.4   Singapore
7.5.2.5   India
7.5.2.6   Rest of Asia Pacific
7.6   Rest of the World

8.1   Agilent Technologies, Inc.
8.1.1   Overview
8.1.2   Overall Product Portfolio
8.1.3   Product Offerings for Global CRISPR Technology Market
8.1.4   Financials
8.1.4.1   Financial Summary
8.1.5   Global Presence
8.1.6   Recent Developments
8.1.7   SWOT Analysis
8.2   Applied StemCell, Inc.
8.2.1   Overview
8.2.2   Corporate Summary
8.2.3   Product Offerings for Global CRISPR Technology Market
8.2.4   Recent Developments
8.2.5   SWOT Analysis
8.3   Cellecta, Inc.
8.3.1   Overview
8.3.2   Corporate Summary
8.3.3   Product Offerings for Global CRISPR Technology Market
8.3.4   SWOT Analysis
8.4   Dharmacon, Inc.
8.4.1   Overview
8.4.2   Overall Product Portfolio
8.4.3   Product Offerings for Global CRISPR Technology Market
8.4.4   Financials
8.4.4.1   Financial Summary
8.4.5   Global Presence
8.4.6   Recent Developments
8.4.7   SWOT Analysis
8.5   DiaCarta, Inc.
8.5.1   Overview
8.5.2   Corporate Summary
8.5.3   Product Offerings for Global CRISPR Technology Market
8.5.4   Global Presence
8.5.5   Recent Developments
8.5.6   SWOT Analysis
8.6   EdiGene, Inc.
8.6.1   Overview
8.6.2   Corporate Summary
8.6.3   Product Offerings for Global CRISPR Technology Market
8.6.4   Recent Developments
8.6.5   SWOT Analysis
8.7   GeneCopoeia, Inc.
8.7.1   Overview
8.7.2   Corporate Summary
8.7.3   Product Offerings for Global CRISPR Technology Market
8.7.4   SWOT Analysis
8.8   Genedata AG
8.8.1   Overview
8.8.2   Corporate Summary
8.8.3   Product Offerings for Global CRISPR Technology Market
8.8.4   Recent Developments
8.8.5   SWOT Analysis
8.9   GenScript
8.9.1   Overview
8.9.2   Overall Product Portfolio
8.9.3   Product Offerings for Global CRISPR Technology Market
8.9.4   Financials
8.9.4.1   Financial Summary
8.9.5   Global Presence
8.9.6   Recent Developments
8.9.7   SWOT Analysis
8.10   Integrated DNA Technologies (IDT), Inc.
8.10.1   Overview
8.10.2   Corporate Summary
8.10.3   Product Offerings for Global CRISPR Technology Market
8.10.4   Recent Developments
8.10.5   SWOT Analysis
8.11   Mirus Bio LLC
8.11.1   Overview
8.11.2   Corporate Summary
8.11.3   Product Offerings for Global CRISPR Technology Market
8.11.4   Recent Developments
8.11.5   SWOT Analysis
8.12   New England Biolabs
8.12.1   Overview
8.12.2   Corporate Summary
8.12.3   Product Offerings for Global CRISPR Technology Market
8.12.4   SWOT Analysis
8.13   OriGene Technologies, Inc.
8.13.1   Overview
8.13.2   Corporate Summary
8.13.3   Product Offerings for Global CRISPR Technology Market
8.13.4   Recent Developments
8.13.5   SWOT Analysis
8.14   Oxford Genetics Ltd.
8.14.1   Overview
8.14.2   Corporate Summary
8.14.3   Product Offerings for Global CRISPR Technology Market
8.14.4   Recent Developments
8.14.5   SWOT Analysis
8.15   Rockland Immunochemicals, Inc.
8.15.1   Overview
8.15.2   Corporate Summary
8.15.3   Product Offerings for Global CRISPR Technology Market
8.15.4   SWOT Analysis
8.16   Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
8.16.1   Overview
8.16.2   Overall Product Portfolio
8.16.3   Product Offerings for Global CRISPR Technology Market
8.16.4   Financials
8.16.4.1   Financial Summary
8.16.5   Global Presence
8.16.6   Recent Developments
8.16.7   SWOT Analysis
8.17   Synthego Corporation
8.17.1   Overview
8.17.2   Corporate Summary
8.17.3   Product Offerings for Global CRISPR Technology Market
8.17.4   Recent Developments
8.17.5   SWOT Analysis
8.18   System Biosciences, LLC
8.18.1   Overview
8.18.2   Corporate Summary
8.18.3   Product Offerings for Global CRISPR Technology Market
8.18.4   SWOT Analysis
8.19   Takara Bio USA Inc. (A Subsidiary of Takara Bio Inc.)
8.19.1   Overview
8.19.2   Overall Product Portfolio
8.19.3   Product Offerings for Global CRISPR Technology Market
8.19.4   Financials
8.19.4.1   Financial Summary
8.19.5   Global Presence
8.19.6   Recent Developments
8.19.7   SWOT Analysis
8.20   Thermo Fisher Scientific Inc.
8.20.1   Overview
8.20.2   Overall Product Portfolio
8.20.3   Product Offerings for Global CRISPR Technology Market
8.20.4   Financials
8.20.4.1   Financial Summary
8.20.5   Global Presence
8.20.6   Recent Developments
8.20.7   SWOT Analysis
8.21   transOMIC technologies inc.
8.21.1   Overview
8.21.2   Corporate Summary
8.21.3   Product Offerings for Global CRISPR Technology Market
8.21.4   Recent Developments
8.21.5   SWOT Analysis
8.22   Transposagen Biopharmaceuticals
8.22.1   Overview
8.22.2   Corporate Summary
8.22.3   Product Offerings for Global CRISPR Technology Market
8.22.4   SWOT Analysis

9.1   Scope of the Report
9.2   Global CRISPR Technology Market Segmentation
9.3   Research Methodology
9.3.1   Primary Research
9.3.2   Secondary Research
9.3.3   Key Data Points from Primary Sources
9.3.4   Key Data Points from Secondary Sources
9.3.5   Data Triangulation
9.3.6   Top-Down Approach (Segment wise Analysis)
9.3.7   Bottom-Up Approach (Segmental Analysis)
9.4   Assumptions and Limitations
9.5   Data and Prediction Modelling

10.1 Annexure 1: Recent Key Developments (2014 – 2018) and Patent Landscape
10.2 Annexure 2: Product Mapping and Pricing Analysis

1   Global CRISPR Technology Market (2017 & 2027)
2   Impact Analysis of Market Dynamics
3   Pipeline Analysis of Biopharmaceutical Companies using CRISPR Technology
4   Funding Scenario of Public Companies
5   Funding Scenario of Private Companies
6   Funding Scenario of Government Organizations
7   List of Regulatory Bodies
8   Europe CRISPR Technology Market, by Country, $Million (2017-2027)
9   Asia Pacific CRISPR Technology Market, by Country, $Million (2017-2027)
10   Agilent Technologies, Inc.: Product Developments
11   Applied StemCell, Inc.: Other Developments
12   Applied StemCell, Inc.: Merger And Acquisition
13   Horizon Discovery plc: Product Developments
14   Horizon Discovery plc: Merger, Acquisition & Collaboration
15   EdiGene, Inc.: Agreements and Other Developments
16   Genedata AG: Agreements and Collaboration
17   Genedata AG: Product Developments
18   Genedata AG: Other Developments
19   GenScript: Product Developments
20   Integrated DNA Technologies, Inc.: Product Developments
21   Integrated DNA Technologies, Inc.: Merger and Acquisition
22   Mirus Bio LLC: Product Developments
23   OriGene Technologies, Inc.: Product Developments
24   Oxford Genetics Ltd.: Agreements and Other Developments
25   Merck KGaA: Partnerships, Collaboration, Acquisition and Joint Venture
26   Merck KGaA: Other Developments
27   Synthego Corporation: Product Developments
28   Synthego Corporation : Other Developments
29   Takara Bio USA Inc.: Product Developments
30   Takara Bio USA Inc.: Merger and Acquisition
31   Thermo Fisher Scientific Inc.: Product Developments
32   Thermo Fisher Scientific Inc.: Merger and Acquisition
33   transOMIC technologies inc.: Product Developments

1   Impact of Market Drivers and Market Restraints
2   Market Statistics
3   Global CRISPR Technology Market, by Product ($Million)
4   Global CRISPR Technology Market, by Product, 2017
5   Global CRISPR Technology Market, by Product, 2027
6   Global CRISPR Technology Market, by Application, 2017
7   Global CRISPR Technology Market, by Application, 2027
8   Global CRISPR Technology Market Value, by Region, 2017 & 2027 ($Million)
9   Global CRISPR Technology Market, by Region, 2017
10   Global CRISPR Technology Market, by Region, 2027
11   Advantages of CRISPR Technology
12   CRISPR Technology Approach
13   Evolution of CRISPR Technology
14   CRISPR Technology: Areas of Interest
15   Future Potential of CRISPR Technology
16   Global CRSIPR Technology Market (2017-2027)
17   Market Dynamics
18   Competitive Landscape (January 2014-February 2018)
19   Share of Key Developments and Strategies (January 2014-February 2018)
20   Product Launch Share, by Companies
21   Joint Ventures, Partnerships, and Collaborations Share, by Companies
22   Porter’s Five Forces Analysis
23   Industry Insights (January 2014-February 2018)
24   Funding Scenario Share, by Type of Companies/Organization
25   CRISPR Technology Market, by Product
26   Global CRISPR Technology Market, by Product (2017-2027)
27   Different Designing Tools
28   Global CRISPR Technology Market, by Designing Tools (2017-2027)
29   Types of Library
30   Global CRISPR Technology Market, by Library (2017-2027)
31   Types of Controls
32   Global CRISPR Technology Market, by Control Kits (2017-2027)
33   Types of Plasmids
34   Global CRISPR Technology Market, by Plasmids (2017-2027)
35   Types of Vectors
36   Global CRISPR Technology Market, by Vectors (2017-2027)
37   Types of Proteins
38   Global CRISPR Technology Market, by Proteins (2017-2027)
39   Global CRISPR Technology Market, by Cas9 (2017-2027)
40   Global CRISPR Technology Market, by Cpf1 (2017-2027)
41   Global CRISPR Technology Market, by Others (2017-2027)
42   Global CRISPR Technology Market, by gRNA (2017-2027)
43   Global CRISPR Technology Market, by Others (2017-2027)
44   Global CRISPR Technology Market Share, by Application, 2017
45   Global CRISPR Technology Market Share, by Application, 2017
46   Global CRISPR Technology Market, by Application (2017-2027)
47   Application of CRISPR Technology in Biological Research
48   Global CRISPR Technology Market, by Biological Research (2017-2027)
49   Application of CRISPR Technology in Agricultural Research
50   Global CRISPR Technology Market, by Agricultural Biotech (2017-2027)
51   Global CRISPR Technology Market, by Industrial Biotech (2017-2027)
52   Global CRISPR Technology Market, by Therapeutics and Drug Discovery (2017-2027)
53   Global CRSIPR Technology Market, by Region (2017-2027)
54   Global CRISPR Technology Market Share, by Region (2017)
55   Global CRISPR Technology Market Share, by Region (2027)
56   North America CRISPR Technology Market (2017-2027)
57   North America CRISPR Technology Market, by Country (2017-2027)
58   The U.S. CRISPR Technology Market (2017-2027)
59   Canada CRISPR Technology Market  (2017-2027)
60   Europe CRISPR Technology Market (2017-2027)
61   The U.K. CRISPR Technology Market (2017-2027)
62   Germany CRISPR Technology Market (2017-2027)
63   France CRISPR Technology Market (2017-2027)
64   Spain CRISPR Technology Market (2017-2027)
65   Italy CRISPR Technology Market (2017-2027)
66   Switzerland CRISPR Technology Market (2017-2027)
67   Rest of the Europe CRISPR Technology Market (2017-2027)
68   Asia Pacific CRISPR Technology Market (2017-2027)
69   Japan CRISPR Technology Market (2017-2027)
70   China CRISPR Technology Market (2017-2027)
71   South Korea CRISPR Technology Market (2017-2027)
72   Singapore CRISPR Technology Market (2017-2027)
73   India CRISPR Technology Market (2017-2027)
74   Rest of Asia Pacific CRISPR Technology Market (2017-2027)
75   Rest of the World CRISPR Technology Market (2017-2027)
76   Agilent Technologies, Inc.: Overall Product Portfolio
77   Agilent Technologies, Inc.: Product Portfolio for Global CRISPR Technology
78   Agilent Technologies, Inc.: Overall Financials (2014-2017)
79   Agilent Technologies, Inc.: Revenue by Business Segment (2014-2017)
80   Agilent Technologies, Inc.: Revenue by Region (2014-2017)
81   Agilent Technologies, Inc.: Global Presence
82   Agilent Technologies, Inc.: SWOT Analysis
83   Applied StemCell, Inc.: Overall Product Portfolio
84   Applied StemCell, Inc.: Product Portfolio for Global CRISPR Technology
85   Applied StemCell, Inc.: SWOT Analysis
86   Cellecta, Inc.: Overall Product Portfolio
87   Cellecta, Inc.: Product Portfolio for Global CRISPR Technology
88   Cellecta, Inc.: SWOT Analysis
89   Horizon Discovery plc: Overall Product Portfolio
90   Horizon Discovery plc (Dharmacon, Inc.): Product Portfolio for Global CRISPR Technology
91   Horizon Discovery plc: Overall Financials (2014-2016)
92   Horizon Discovery plc: Net Revenue by Business Segment (2014-2016)
93   Horizon Discovery plc: Net Revenue by Region (2014-2016)
94   Horizon Discovery plc: Global Presence
95   Horizon Discovery plc: SWOT Analysis
96   EdiGene, Inc.: Overall Product Portfolio
97   EdiGene, Inc.: Product Portfolio for Global CRISPR Technology
98   EdiGene, Inc.: SWOT Analysis
99   GeneCopoeia, Inc.: Overall Product Portfolio
100   GeneCopoeia, Inc.: Product Portfolio for Global CRISPR Technology
101   GeneCopoeia, Inc.: SWOT Analysis
102   Genedata AG: Overall Product Portfolio
103   Genedata AG: Product Portfolio for Global CRISPR Technology
104   Genedata AG: SWOT Analysis
105   GenScript: Overall Product Portfolio
106   GenScript: Product Portfolio for Global CRISPR Technology
107   GenScript: Overall Financials (2014-2016)
108   GenScript: Net Revenue by Business Segment (2014-2016)
109   GenScript: Net Revenue by Region (2014-2016)
110   GenScript: Global Presence
111   GenScript: SWOT Analysis
112   Integrated DNA Technologies, Inc.: Overall Product Portfolio
113   Integrated DNA Technologies, Inc.: Product Portfolio for Global CRISPR Technology
114   Integrated DNA Technologies, Inc.: SWOT Analysis
115   Mirus Bio LLC : Overall Product Portfolio
116   Mirus Bio LLC: Product Portfolio for Global CRISPR Technology
117   Mirus Bio LLC: SWOT Analysis
118   New England Biolabs: Overall Product Portfolio
119   New England Biolabs: Product Portfolio for Global CRISPR Technology
120   New England Biolabs: SWOT Analysis
121   OriGene Technologies, Inc.: Overall Product Portfolio
122   OriGene Technologies, Inc.: Product Portfolio for Global CRISPR Technology
123   OriGene Technologies, Inc.: SWOT Analysis
124   Oxford Genetics Ltd.: Overall Product Portfolio
125   Oxford Genetics Ltd. : Product Portfolio for Global CRISPR Technology
126   Oxford Genetics Ltd.: SWOT Analysis
127     Rockland Immunochemicals, Inc: Overall Product Portfolio
128   Rockland Immunochemicals, Inc: Product Portfolio for Global CRISPR Technology
129   Rockland Immunochemicals, Inc: SWOT Analysis
130   Merck KGaA: Overall Product Portfolio
131   Merck KGaA (Sigma Aldrich Corporation): Product Portfolio for Global CRISPR Technology
132   Merck KGaA: Overall Financials, (2014-2016)
133   Merck KGaA: Net Revenue by Business Segments, (2014-2016)
134   Merck KGaA: Net Revenue by Geography, (2014)
135   Merck KGaA: Net Revenue by Geography, (2015-2016)
136   Merck KGaA: Global Presence
137   Merck KGaA: SWOT Analysis
138   Synthego Corporation: Overall Product Portfolio
139   Synthego Corporation: Product Portfolio for Global CRISPR Technology
140   Synthego Corporation: SWOT Analysis
141   System Biosciences, LLC: Overall Product Portfolio
142   System Biosciences, LLC: Product Portfolio for Global CRISPR Technology
143   System Biosciences, LLC: SWOT Analysis
144   Takara Bio Inc. : Overall Product Portfolio
145   Takara Bio Inc. (Takara Bio USA Inc.): Product Portfolio for Global CRISPR Technology
146   Takar Bio Inc.: Overall Financials (2014-2017)
147   Takara Bio Inc.: Net Revenue by Business Segment (2014-2017)
148   Takara Bio Inc.: Net Revenue by Region (2014-2017)
149   Takara Bio Inc.: Global Presence
150   Takara Bio Inc.: SWOT Analysis
151   Thermo Fisher Scientific Inc.: Overall Product Portfolio
152   Thermo Fisher Scientific Inc.: Product Portfolio for Global CRISPR Technology
153   Thermo Fisher Scientific Inc.: Overall Financials (2014-2017)
154   Thermo Fisher Scientific Inc.: Net Revenue by Business Segment (2014-2017)
155   Thermo Fisher Scientific Inc.: Net Revenue by Region (2014-2016)
156   Thermo Fisher Scientific Inc.: Global Presence
157   Thermo Fisher Scientific Inc.- SWOT Analysis
158   transOMIC technologies inc.: Overall Product Portfolio
159   transOMIC technologies inc.: Product Portfolio for Global CRISPR Technology
160   transOMIC technologies inc.: SWOT Analysis
161   Transposagen Biopharmaceuticals: Overall Product Portfolio
162   Transposagen Biopharmaceuticals: Product Portfolio for Global CRISPR Technology
163   Transposagen Biopharmaceuticals: SWOT Analysis
164   Global CRISPR Technology Market Segmentation
165   Considered Factors for Data Prediction & Modeling